Clinical Significance of Salvage Esophagectomy for Patients with Esophageal Cancer and Factors of Influencing Long-term Survival

被引:15
作者
Sohda, Makoto [1 ]
Kumakura, Yuji [1 ]
Saito, Hideyuki [1 ]
Kuriyama, Kengo [1 ]
Yoshida, Tomonori [1 ]
Honjyo, Hiroaki [1 ]
Hara, Keigo [1 ]
Ozawa, Daigo [1 ]
Suzuki, Shigemasa [1 ]
Tanaka, Naritaka [1 ]
Sakai, Makoto [1 ]
Miyazaki, Tatsuya [1 ]
Fukuchi, Minoru [1 ]
Kuwano, Hiroyuki [1 ]
机构
[1] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan
关键词
Esophageal cancer; salvage esophagectomy; long-term survival; SQUAMOUS-CELL CARCINOMA; DEFINITIVE CHEMORADIOTHERAPY; 5-FLUOROURACIL; CISPLATIN; OUTCOMES; DOCETAXEL; SURGERY; FAILURE;
D O I
10.21873/anticanres.11920
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background/Aim: Definitive chemoradiotherapy (CRT) without planned surgery has been recently widely used as a therapeutic option for locally advanced esophageal cancer. Salvage esophagectomy can offer the chance of prolonged survival for patients who have locoregional failure after definitive CRT, but many clinicians oppose the use of surgery due to the associated excessive morbidity and mortality. The aim of this study was to identify patients who are good candidates for salvage surgery by investigating factors influencing long-term survival. Patients and Methods: A total of 40 patients underwent concurrent CRT or RT followed by esophagectomy for residual tumor or locoregional recurrence of esophageal squamous cell carcinoma without distant organ metastasis at the Department of General Surgical Science, Gunma University, Gunma, Japan, and were included in this study. As short-term outcomes after salvage esophagectomy, pulmonary and cardiovascular complications, anastomotic leakage, and chylothorax, and the length of postoperative stay were evaluated. Survival rates were calculated using the Kaplan-Meier method, and the Cox proportional hazards model was used for univariate and multivariate analyses of disease-specific survival. Results: Postoperative complications were noted in 20 patients (50%), and pulmonary complications were the most common (25%), followed by anastomotic leakage (20%). There was also one case of in-hospital death, caused by multiple organ failure due to chylothorax. Univariate analysis revealed that sex, clinical residual tumor, CRT response, pathological tumor depth, and pathological residual tumor were significant factors affecting disease-specific survival (p= 0.034, p= 0.009, p= 0.014, p= 0.020, and p= 0.026, respectively). Moreover, multivariate analysis demonstrated that clinical residual tumor was the only independent factor influencing disease-specific survival (p= 0.036). Thirteen patients (32.5%) died from other illnesses after salvage surgery, 53.8% patients from pneumonia. Conclusion: Based on long-term survival, recurrence rather than residual tumor after definitive CRT was a favorable indicator for salvage esophagectomy. Not only management of postoperative morbidity and curative operation but, also long-term rigorous outpatient management, including respiratory rehabilitation to reduce pneumonia, is necessary.
引用
收藏
页码:5045 / 5051
页数:7
相关论文
共 24 条
  • [1] Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years
    Ando, N
    Ozawa, S
    Kitagawa, Y
    Shinozawa, Y
    Kitajima, M
    [J]. ANNALS OF SURGERY, 2000, 232 (02) : 225 - 232
  • [2] Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus
    Chao, Y. K.
    Chan, S. C.
    Chang, H. K.
    Liu, Y. H.
    Wu, Y. C.
    Hsieh, M. J.
    Tseng, C. K.
    Liu, H. P.
    [J]. EJSO, 2009, 35 (03): : 289 - 294
  • [3] Chemoradiotherapy of locally advanced esophageal cancer - Long-term follow-up of a prospective randomized trial (RTOG 85-01)
    Cooper, JS
    Guo, MD
    Herskovic, A
    Macdonald, JS
    Martenson, JA
    Al-Sarraf, M
    Byhardt, R
    Russell, AH
    Beitler, JJ
    Spencer, S
    Asbell, SO
    Graham, MV
    Leichman, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (17): : 1623 - 1627
  • [4] Salvage oesophagectomy after local failure of definitive chemoradiotherapy
    Gardner-Thorpe, J.
    Hardwick, R. H.
    Dwerryhouse, S. J.
    [J]. BRITISH JOURNAL OF SURGERY, 2007, 94 (09) : 1059 - 1066
  • [5] Definitive Chemoradiation Therapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-R) in Advanced Esophageal Cancer: A Phase 2 Trial (KDOG 0501-P2)
    Higuchi, Katsuhiko
    Komori, Shouko
    Tanabe, Satoshi
    Katada, Chikatoshi
    Azuma, Mizutomo
    Ishiyama, Hiromichi
    Sasaki, Tohru
    Ishido, Kenji
    Katada, Natsuya
    Hayakawa, Kazushige
    Koizumi, Wasaburo
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 89 (04): : 872 - 879
  • [6] Treatment outcomes of resected esophageal cancer
    Hofstetter, W
    Swisher, SG
    Correa, AM
    Hess, K
    Putnam, JB
    Ajani, JA
    Dolormente, M
    Francisco, R
    Komaki, RR
    Lara, A
    Martin, F
    Rice, DC
    Sarabia, AJ
    Smythe, WR
    Vaporciyan, AA
    Walsh, GL
    Roth, JA
    [J]. ANNALS OF SURGERY, 2002, 236 (03) : 376 - 385
  • [7] Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus
    Ishikura, S
    Nihei, K
    Ohtsu, A
    Boku, N
    Hironaka, S
    Mera, K
    Muto, M
    Ogino, TG
    Yoshida, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (14) : 2697 - 2702
  • [8] Japanese Society for Esophageal Disease, 2008, GUID CLIN PATH STUD
  • [9] JEMAL A, 2014, CA-CANCER J CLIN, V61, P69, DOI DOI 10.3322/CAAC.20107
  • [10] PHASE II STUDY OF CHEMORADIOTHERAPY WITH 5-FLUOROURACIL AND CISPLATIN FOR STAGE II-III ESOPHAGEAL SQUAMOUS CELL CARCINOMA: JCOG TRIAL (JCOG 9906)
    Kato, Ken
    Muro, Kei
    Minashi, Keiko
    Ohtsu, Atsushi
    Ishikura, Satoshi
    Boku, Narikazu
    Takiuchi, Hiroya
    Komatsu, Yoshito
    Miyata, Yoshinori
    Fukuda, Haruhiko
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (03): : 684 - 690